Literature DB >> 22917659

A global assessment of the oesophageal adenocarcinoma epidemic.

Gustaf Edgren1, Hans-Olov Adami, Elisabete Weiderpass, Elisabete Weiderpass Vainio, Olof Nyrén.   

Abstract

OBJECTIVE: About 20 years ago, the scientific community was first alerted to an enigmatic increase of oesophageal adenocarcinomas in the UK and USA. Subsequently, a virtual epidemic-still unexplained-was confirmed in several western countries. Detailed descriptive data might provide clues to its causes.
DESIGN: We collected data on incident cases of oesophageal adenocarcinoma from population-based cancer registries in Australia, Europe, North America and Asia. We calculated age-standardised incidence rates and fitted log-linear Poisson models to assess annual rate of increase and to disentangle age-period-cohort effects, linear spine models to estimate rate of increase since 1985, and Joinpoint models to identify possible inflection points.
RESULTS: With considerable between-registry variation in magnitude and timing, we found a consistent dramatic increase in incidence with an observed or estimated start between 1960 and 1990. The average annual increase ranged from 3.5% in Scotland to 8.1% in Hawaii with similar proportional increase among men and women in most registries and a maintained three to sixfold higher incidence among men. Generally, calendar period was a more important determinant of incidence trends than birth cohort. Where possible to conduct, Joinpoint analyses indicated that the onset of the epidemic varied considerably even between neighbouring countries.
CONCLUSIONS: Given the preponderant period effect and the abrupt onset observed or inferred in most populations, the epidemic appears to be caused by some exposure that was first introduced around 1950. At least 30 years' variation in estimated time of onset opens prospects for hypothesis-generating ecological analyses.

Entities:  

Keywords:  Helicobacter pylori; Oesophageal cancer; adenocarcinoma; biostatistics; cancer; cancer epidemiology; cancer prevention; cancer vaccines; epidemiology; gastric adenocarcinoma; gastric cancer; screening

Mesh:

Year:  2012        PMID: 22917659     DOI: 10.1136/gutjnl-2012-302412

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  122 in total

Review 1.  The role of obesity in oesophageal cancer development.

Authors:  Elizabeth Long; Ian L P Beales
Journal:  Therap Adv Gastroenterol       Date:  2014-11       Impact factor: 4.409

Review 2.  Minimally invasive esophagectomy for Barrett's adenocarcinoma.

Authors:  Emanuele Asti; Daniele Bernardi; Marco Sozzi; Luigi Bonavina
Journal:  Transl Gastroenterol Hepatol       Date:  2018-10-16

Review 3.  How does genome sequencing impact surgery?

Authors:  Marlies S Reimers; Charla C Engels; Peter J K Kuppen; Cornelis J H van de Velde; Gerrit J Liefers
Journal:  Nat Rev Clin Oncol       Date:  2014-06-24       Impact factor: 66.675

Review 4.  Palliative chemotherapy and targeted therapies for esophageal and gastroesophageal junction cancer.

Authors:  Vincent T Janmaat; Ewout W Steyerberg; Ate van der Gaast; Ron Hj Mathijssen; Marco J Bruno; Maikel P Peppelenbosch; Ernst J Kuipers; Manon Cw Spaander
Journal:  Cochrane Database Syst Rev       Date:  2017-11-28

5.  Enigmas, priorities and opportunities in cancer epidemiology.

Authors:  Hans-Olov Adami; Olof Nyrén
Journal:  Eur J Epidemiol       Date:  2017-01-06       Impact factor: 8.082

6.  Is the incidence of esophageal adenocarcinoma increasing in Japan? Trends from the data of a hospital-based registration system in Akita Prefecture, Japan.

Authors:  Shigeto Koizumi; Satoru Motoyama; Katsunori Iijima
Journal:  J Gastroenterol       Date:  2017-11-14       Impact factor: 7.527

Review 7.  Endoscopic Screening for Barrett's Esophagus and Esophageal Adenocarcinoma: Rationale, Candidates, and Challenges.

Authors:  Amrit K Kamboj; David A Katzka; Prasad G Iyer
Journal:  Gastrointest Endosc Clin N Am       Date:  2020-10-21

8.  Obesity and the Incidence of Upper Gastrointestinal Cancers: An Ecological Approach to Examine Differences across Age and Sex.

Authors:  Melina Arnold; Amy Colquhoun; Michael B Cook; Jacques Ferlay; David Forman; Isabelle Soerjomataram
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-10-22       Impact factor: 4.254

Review 9.  HER2 heterogeneity in gastric/gastroesophageal cancers: From benchside to practice.

Authors:  Federica Grillo; Matteo Fassan; Francesca Sarocchi; Roberto Fiocca; Luca Mastracci
Journal:  World J Gastroenterol       Date:  2016-07-14       Impact factor: 5.742

Review 10.  Microbiome and potential targets for chemoprevention of esophageal adenocarcinoma.

Authors:  Antonio Galvao Neto; April Whitaker; Zhiheng Pei
Journal:  Semin Oncol       Date:  2015-09-07       Impact factor: 4.929

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.